Last reviewed · How we verify
NCT05950828
Evaluating the Impact of Online Educator Microskill Training on Educator Knowledge and Skill
NA trial testing SkillTalk in HIV/AIDS Prevention in 79 participants. Completed in 24 October 2024.
31 August 2024
Quick facts
| Lead sponsor | Philliber Research & Evaluation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 79 |
| Start date | 9 August 2022 |
| Primary completion | 31 August 2024 |
| Estimated completion | 24 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SkillTalk
Conditions studied
- HIV/AIDS Prevention — all drugs for HIV/AIDS Prevention →
- STI Prevention — all drugs for STI Prevention →
- Pregnancy Prevention — all drugs for Pregnancy Prevention →
Sponsor
Philliber Research & Evaluation
Who can join
18 and older, any sex, with HIV/AIDS Prevention or STI Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the efficacy of SkillTalk, a subscription-based microskills video training library designed to enhance the skills of high school sex educators to implement the frequently used core components of sexual and reproductive health (SRH) curricula. The overall goal of this study is to evaluate the impact of SkillTalk on educators' demonstrable sexual health education skills. Participants will be asked to: * Complete a consent form. * Attend two simulated classroom sessions, either in person or virtually, during which they will teach two prepared lessons that have will be provided to them. * Be video recorded while teaching. * Complete a baseline survey and a post-survey. * If assigned to the treatment group, they will be granted access to SkillTalk for one week to view the videos associated with the answering sensitive questions and using trauma-informed strategies skill sets. Researchers will compare the treatment group to the control group to see if SkillTalk has an impact on educators' demonstrable sexual health education skills.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05950828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SkillTalk
Trials testing the same drug.
- NCT05952973 — The Impact of Online Educator Mircoskill Training and Parent Microskill Training on Student Sexual-Health Related Outcom · NA · completed
Other Philliber Research & Evaluation trials
Trials by the same sponsor.
- NCT04494477 — Evaluation of the Impact of the IN•Clued Curriculum: An LGBTQ Sex ed Program · NA · completed
- NCT04451031 — Evaluation of the Impact of Linking Families and Teens (LiFT) Curriculum · NA · completed
- NCT04508569 — Evaluation of Big Decisions in Three South Texas School Districts · NA · completed
- NCT04441294 — The Evaluation of Achieving Condom Empowerment (ACE)-Plus in New York City · NA · unknown
- NCT05087004 — Planned Parenthood Teen Council Program Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05950828 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philliber Research & Evaluation
- Last refreshed: 22 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05950828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing